CPT code 46924 represents the extensive destruction of anal lesions — such as condyloma, papilloma, molluscum contagiosum, or herpetic vesicles — using modalities like laser, electrocautery, cryotherapy, or chemical agents. Nationally, this code captures procedures that require more comprehensive lesion removal in the anal region and carries implications for coding accuracy, payer coverage, and outpatient procedural workflows.

Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The review covers common coverage considerations and clinical context relevant to these payers, with attention to how the procedure is typically performed in ambulatory and clinic settings.

Readers will learn what CPT code 46924 denotes clinically, where the service is commonly delivered, and which major payers are relevant for coverage considerations. The publication provides benchmarks and policy-relevant context where available, highlights clinical scenarios that commonly generate use of this code, and identifies missing data elements that affect comparative analyses. Data not available in the input is noted explicitly for transparency.